Solid-state nuclear magnetic resonance evidence for parallel and antiparallel strand arrangements in the membrane-associated HIV-1 fusion peptide

Biochemistry

Volumn 42, Issue 40, 2003, Pages 11879-11890

  Yang, Jun ^a   Weliky, David P ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID-MIXING STAGE;

BIOLOGICAL MEMBRANES; CELLS; CONFORMATIONS; HYDROGEN BONDS; LIPIDS;

BIOCHEMISTRY;

AMIDE; CARBONYL DERIVATIVE; GLYCINE; OLIGOMER; PEPTIDE; WATER;

ARTICLE; CELL FUSION; CELL MEMBRANE; HOST CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROGEN BOND; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; TARGET CELL; VIRUS CELL INTERACTION;

AMINO ACID SEQUENCE; CALIBRATION; HIV ENVELOPE PROTEIN GP41; HIV-1; MEMBRANE FUSION; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDE FRAGMENTS; VIRAL FUSION PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0141954182     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0348157     Document Type: Article

References (112)

1. Hernandez, L. D., Hoffman, L. R., Wolfsberg, T. G., and White, J. M. (1996) Virus-cell and cell-cell fusion, Annu. Rev. Cell Dev. Biol. 12, 627-661.
2. Dimitrov, D. S. (2000) Cell biology of virus entry, Cell 101, 697-702.
3. Eckert, D. M., and Kim, P. S. (2001) Mechanisms of viral membrane fusion and its inhibition, Annu. Rev. Biochem. 70, 777-810.
4. Blumenthal, R., Clague, M. J., Durell, S. R., and Epand, R. M. (2003) Membrane fusion, Chem. Rev. 103, 53-69.
5. Freed, E. O., Myers, D. J., and Risser, R. (1990) Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41, Proc. Natl. Acad. Sci. U.S.A. 87, 4650-4654.
6. Rafalski, M., Lear, J. D., and DeGrado, W. F. (1990) Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41, Biochemistry 29, 7917-7922.
7. Slepushkin, V. A., Melikyan, G. B., Sidorova, M. S., Chumakov, V. M., Andreev, S. M., Manulyan, R. A., and Karamov, E. V. (1990) Interaction of human immunodeficiency virus (HIV-1) fusion peptides with artificial lipid membranes, Biochem. Biophys. Res. Commun. 172, 952-957.
8. Freed, E. O., Delwart, E. L., Buchschacher, G. L., Jr., and Panganiban, A. T. (1992) A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity, Proc. Natl. Acad. Sci. U.S.A. 89, 70-74.
9. 2-terminal HIV-1 gp41 peptide in fused and aggregated liposomes, Biochim. Biophys. Acta 1145, 124-133.
10. Nieva, J. L., Nir, S., Muga, A., Goni, F. M., and Wilschut, J. (1994) Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage, Biochemistry 33, 3201-3209.
11. Mobley, P. W., Lee, H. F., Curtain, C. C., Kirkpatrick, A., Waring, A. J., and Gordon, L. M. (1995) The amino-terminal peptide of HIV-1 glycoprotein 41 fuses human erythrocytes, Biochim. Biophys. Acta 1271, 304-314.
12. Schaal, H., Klein, M., Gehrmann, P., Adams, O., and Scheid, A. (1995) Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion, J. Virol. 69, 3308-3314.
13. Delahunty, M. D., Rhee, I., Freed, E. O., and Bonifacino, J. S. (1996) Mutational analysis of the fusion peptide of the human immunodeficiency virus type 1: identification of critical glycine residues, Virology 218, 94-102.
14. Martin, I., Schaal, H., Scheid, A., and Ruysschaert, J. M. (1996) Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer, J. Virol. 70, 298-304.
15. Durell, S. R., Martin, I., Ruysschaert, J. M., Shai, Y., and Blumenthal, R. (1997) What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion (review), Mol. Membr. Biol. 14, 97-112.
16. Kliger, Y., Aharoni, A., Rapaport, D., Jones, P., Blumenthal, R., and Shai, Y. (1997) Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell Fusion. Structure-function study, J. Biol. Chem. 272, 13496-13505.
17. Pereira, F. B., Goni, F. M., Muga, A., and Nieva, J. L. (1997) Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects, Biophys. J. 73, 1977-1986.
18. Nieva, J. L., Nir, S., and Wilschut, J. (1998) Destabilization and fusion of zwitterionic large unilamellar lipid vesicles induced by a β-type structure of the HIV-1 fusion peptide, J. Liposome Res. 8, 165-182.
19. Pecheur, E., Sainte-Marie, J., Bienvenue, A., and Hoekstra, D. (1999) Peptides and membrane fusion: towards an understanding of the molecular mechanism of protein-induced fusion, J. Membr. Biol. 167, 1-17.
20. Pritsker, M., Rucker, J., Hoffman, T. L., Doms, R. W., and Shai, Y. (1999) Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes, Biochemistry 38, 11359-11371.
21. Epand, R. F., Macosko, J. C., Russell, C. J., Shin, Y. K., and Epand, R. M. (1999) The ectodomain of HA2 of influenza virus promotes rapid pH dependent membrane fusion, J. Mol. Biol. 286, 489-503.
22. Peisajovich, S. G., Epand, R. F., Pritsker, M., Shai, Y., and Epand, R. M. (2000) The polar region consecutive to the HIV fusion peptide participates in membrane fusion, Biochemistry 39, 1826-1833.
23. Peisajovich, S. G., Samuel, O., and Shai, Y. (2000) Paramyxovirus F1 protein has two fusion peptides: implications for the mechanism of membrane fusion, J. Mol. Biol. 296, 1353-1365.
24. Suarez, T., Gallaher, W. R., Agirre, A., Goni, F. M., and Nieva, J. L. (2000) Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion, J. Virol. 74, 8038-8047.
25. Sackett, K., and Shai, Y. (2002) The HIV-1 gp41 N-Terminal Heptad Repeat Plays an Essential Role in Membrane Fusion, Biochemistry 41, 4678-4685.
26. Peisajovich, S. G., Blank, L., Epand, R. F., Epand, R. M., and Shai, Y. (2003) On the interaction between gp41 and membranes: The immunodominant loop stabilizes gp41 helical hairpin conformation, J. Mol. Biol. 326, 1489-1501.
27. Wilson, I. A., Skehel, J. J., and Wiley, D. C. (1981) Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution, Nature 289, 366-373.
28. Bullough, P. A., Hughson, F. M., Skehel, J. J., and Wiley, D. C. (1994) Structure of influenza haemagglutinin at the pH of membrane fusion, Nature 371, 37-43.
29. Chan, D. C., Fass, D., Berger, J. M., and Kim, P. S. (1997) Core structure of gp41 from the HIV envelope glycoprotein, Cell 89, 263-273.
30. Tan, K., Liu, J., Wang, J., Shen, S., and Lu, M. (1997) Atomic structure of a thermostable subdomain of HIV-1 gp41, Proc. Natl. Acad. Sci. U.S.A. 94, 12303-12308.
31. Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J., and Wiley, D. C. (1997) Atomic structure of the ectodomain from HIV-1 gp41, Nature 387, 426-430.
32. Caffrey, M., Cai, M., Kaufman, J., Stahl, S. J., Wingfield, P. T., Covell, D. G., Gronenborn, A. M., and Clore, G. M. (1998) Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41, EMBO J. 17, 4572-4584.
33. Chen, J., Skehel, J. J., and Wiley, D. C. (1999) N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA2 subunit to form an N cap that terminates the triple-stranded coiled coil, Proc. Natl. Acad. Sci. U.S.A. 96, 8967-8972.
34. Yang, Z. N., Mueser, T. C., Kaufman, J., Stahl, S. J., Wingfield, P. T., and Hyde, C. C. (1999) The crystal structure of the SIV gp41 ectodomain at 1.47 Å resolution, J. Struct. Biol. 126, 131-144.
35. Gordon, L. M., Curtain, C. C., Zhong, Y. C., Kirkpatrick, A., Mobley, P. W., and Waring, A. J. (1992) The amino-terminal peptide of HIV-1 glycoprotein 41 interacts with human erythrocyte membranes: peptide conformation, orientation and aggregation, Biochim. Biophys. Acta 1139, 257-274.
36. Pereira, F. B., Goni, F. M., and Nieva, J. L. (1995) Liposome destabilization induced by the HIV-1 fusion peptide effect of a single amino acid substitution, FEBS Lett. 362, 243-246.
37. Chang, D. K., Cheng, S. F., and Chien, W. J. (1997) The amino-terminal fusion domain peptide of human immunodeficiency virus type 1 gp41 inserts into the sodium dodecyl sulfate micelle primarily as a helix with a conserved glycine at the micelle-water interface, J. Virol. 71, 6593-6602.
38. Macosko, J. C., Kim, C. H., and Shin, Y. K. (1997) The membrane topology of the fusion peptide region of influenza hemagglutinin determined by spin-labeling EPR, J. Mol. Biol. 267, 1139-1148.
39. Mobley, P. W., Waring, A. J., Sherman, M. A., and Gordon, L. M. (1999) Membrane interactions of the synthetic N-terminal peptide of HIV-1 gp41 and its structural analogues, Biochim. Biophys. Acta 1418, 1-18.
40. Curtain, C., Separovic, F., Nielsen, K., Craik, D., Zhong, Y., and Kirkpatrick, A. (1999) The interactions of the N-terminal fusogenic peptide of HIV-1 gp41 with neutral phospholipids, Eur. Biophys. J. 28, 427-436.
41. Han, X., and Tamm, L. K. (2000) A host-guest system to study structure-function relationships of membrane fusion peptides, Proc. Natl. Acad. Sci. U.S.A. 97, 13097-13102.
42. Han, X., and Tamm, L. K. (2000) pH-dependent self-association of influenza hemagglutinin fusion peptides in lipid bilayers, J. Mol. Biol. 304, 953-965.
43. Dubovskii, P. V., Li, H., Takahashi, S., Arseniev, A. S., and Akasaka, K. (2000) Structure of an analog of fusion peptide from hemagglutinin, Protein Sci. 9, 786-798.
44. Han, X., Bushweller, J. H., Cafiso, D. S., and Tamm, L. K. (2001) Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin, Nat. Struct. Biol. 8, 715-720.
45. Yang, J., Gabrys, C. M., and Weliky, D. P. (2001) Solid-state nuclear magnetic resonance evidence for an extended β strand conformation of the membrane-bound HIV-1 fusion peptide, Biochemistry 40, 8126-8137.
46. Hsu, C. H., Wu, S. H., Chang, D. K., and Chen, C. P. (2002) Structural characterizations of fusion peptide analogs of influenza virus hemagglutinin-Implication of the necessity of a helix-hinge-helix motif in fusion activity, J. Biol. Chem. 277, 22725-22733.
47. Gordon, L. M., Mobley, P. W., Pilpa, R., Sherman, M. A., and Waring, A. J. (2002) Conformational mapping of the N-terminal peptide of HIV-1 gp41 in membrane environments using C-13-enhanced Fourier transform infrared spectroscopy, Biochim. Biophys. Acta 1559, 96-120.
48. Yang, J., Parkanzky, P. D., Bodner, M. L., Duskin, C. G., and Weliky, D. P. (2002) Application of REDOR subtraction for filtered MAS observation of labeled backbone carbons of membrane-bound fusion peptides, J. Magn. Reson. 159, 101-110.
49. Yang, R., Yang, J., and Weliky, D. P. (2003) Synthesis, enhanced fusogenicity, and solid-state NMR measurements of cross-linked HIV-1 fusion peptides, Biochemistry 42, 3527-3535.
50. 13C NMR spectra of selectively and uniformly labeled fusion peptides associated with membranes, Magn. Reson. Chem. (in press).
51. LeDuc, D. L., Shin, Y. K., Epand, R. F., and Epand, R. M. (2000) Factors determining vesicular lipid mixing induced by shortened constructs of influenza hemagglutinin, Biochemistry 39, 2733-2739.
52. Epand, R. M., Epand, R. F., Martin, I., and Ruysschaert, J. M. (2001) Membrane interactions of mutated forms of the influenza fusion peptide, Biochemistry 40, 8800-8807.
53. Kamath, S., and Wong, T. C. (2002) Membrane structure of the human immunodeficiency virus gp41 fusion domain by molecular dynamics simulation, Biophys. J. 83, 135-143.
54. Maddox, M. W., and Longo, M. L. (2002) Conformational partitioning of the fusion peptide of HIV-1 gp41 and its structural analogues in bilayer membranes, Biophys. J. 83, 3088-3096.
55. Tamm, L. K., Han, X., Li, Y. L., and Lai, A. L. (2002) Structure and function of membrane fusion peptides, Biopolymers 66, 249-260.
56. Wong, T. C. (2003) Membrane structure of the human immunodeficiency virus gp41 fusion peptide by molecular dynamics simulation II. The glycine mutants, Biochim. Biophys. Acta 1609, 45-54.
57. Taylor, S. E., Desbat, B., Blaudez, D., Jacobi, S., Chi, L. F., Fuchs, H., and Schwarz, G. (2000) Structure of a fusion peptide analogue at the air-water interface, determined from surface activity, infrared spectroscopy and scanning force microscopy, Biophys. Chem. 87, 63-72.
58. Haque, M. E., Koppaka, V., Axelsen, P. H., and Lentz, B. R. (2002) Relation between bilayer properties and structures of HA and HIV fusion peptide-membrane complexes, Biophys. J. 82, 540a.
59. Munoz-Barroso, I., Durell, S., Sakaguchi, K., Appella, E., and Blumenthal, R. (1998) Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41, J. Cell Biol. 140, 315-323.
60. Bentz, J. (2000) Minimal aggregate size and minimal fusion unit for the first fusion pore of influenza hemagglutinin-mediated membrane fusion, Biophys. J. 78, 227-245.
61. Bentz, J. (2000) Membrane fusion mediated by coiled coils: a hypothesis, Biophys. J. 78, 886-900.
62. Gullion, T., and Schaefer, J. (1989) Rotational-echo double-resonance NMR, J. Magn. Reson. 81, 196-200.
63. 15N]acetyl-L-camitine. Rotational-echo, double-resonance nuclear magnetic resonance spectroscopy, J. Am. Chem. Soc. 117, 10546-10550.
64. Gullion, T. (1998) Introduction to rotational-echo, double-resonance NMR, Concepts Magn. Reson. 10, 277-289.
65. Balbach, J. J., Ishii, Y., Antzutkin, O. N., Leapman, R. D., Rizzo, N. W., Dyda, F., Reed, J., and Tycko, R. (2000) Amyloid fibril formation by Aβ 16-22, a seven-residue fragment of the Alzheimer's β-amyloid peptide, and structural characterization by solid-state NMR, Biochemistry 39, 13748-13759.
66. 13C REDOR NMR, J. Mol. Struct. 562, 197-203.
67. Murphy, O. J., III, Kovacs, F. A., Sicard, E. L., and Thompson, L. K. (2001) Site-directed solid-state NMR measurement of a ligand-induced conformational change in the serine bacterial chemoreceptor, Biochemistry 40, 1358-1366.
68. 15N labeled membrane protein: Distances between the Schiff base and aspartic acids in the active site of bacteriorhodopsin, J. Am. Chem. Soc. 123, 12929-12930.
69. Smith, S. O., Eilers, M., Song, D., Crocker, E., Ying, W. W., Groesbeek, M., Metz, G., Ziliox, M., and Aimoto, S. (2002) Implications of threonine hydrogen bonding in the glycophorin A transmembrane helix dimer, Biophys. J. 82, 2476-2486.
70. Thompson, L. K. (2002) Solid-state NMR studies of the structure and mechanisms of proteins, Curr. Opin. Struct. Biol. 12, 661-669.
71. + channel helical bundle combining precise orientational and distance restraints from solid-state NMR, Biochemistry 41, 13170-13177.
72. Cegelski, L., Kim, S. J., Hing, A. W., Studelska, D. R., O'Connor, R. D., Mehta, A. K., and Schaefer, J. (2002) Rotational-echo double resonance characterization of the effects of vancomycin on cell wall synthesis in Staphylococcus aureus, Biochemistry 41, 13053-13058.
73. 10-helix contents of a helical peptide, J. Am. Chem. Soc. 120, 7039-7048.
74. Chang, C. D., Waki, M., Ahmad, M., Meienhofer, J., Lundell, E. O., and Haug, J. D. (1980) Preparation and properties of N-α -9-fluorenylmethyloxycarbonylamino acids bearing tert-butyl side-chain protection, Int. J. Pept. Protein Res. 15, 59-66.
75. Lapatsanis, L., Milias, G., Froussios, K., and Kolovos, M. (1983) Synthesis of N-2,2,2-(trichloroethoxycarbonyl)-L-amino acids and N-(9-fluorenylmethoxycarbonyl)-L-amino acids involving succinimidoxy anion as a leaving group in amino acid protection, Synthesis 8, 671-673.
76. Aloia, R. C., Tian, H., and Jensen, F. C. (1993) Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes, Proc. Natl. Acad. Sci. U.S.A. 90, 5181-5185.
77. Hope, M. J., Bally, M. B., Webb, G., and Cullis, P. R. (1985) Production of large unilamellar vesicles by a rapid extrusion procedure-characterization of size distribution, trapped volume and ability to maintain a membrane-potential, Biochim. Biophys. Acta 812, 55-65.
78. Struck, D. K., Hoekstra, D., and Pagano, R. E. (1981) Use of resonance energy transfer to monitor membrane fusion, Biochemistry 20, 4093-4099.
79. Bennett, A. E., Rienstra, C. M., Auger, M., Lakshmi, K. V., and Griffin, R. G. (1995) Heteronuclear decoupling in rotating solids, J. Chem. Phys. 103, 6951-6958.
80. Gullion, T., Baker, D. B., and Conradi, M. S. (1990) New, compensated Carr-Purcell sequences, J. Magn. Reson. 89, 479-484.
81. Gullion, T., and Schaefer, J. (1991) Elimination of resonance offset effects in rotational-echo, double-resonance NMR, J. Magn. Reson. 92, 439-442.
82. McDowell, L. M., Holl, S. M., Qian, S. J., Li, E., and Schaefer, J. (1993) Inter-tryptophan distances in rat cellular retinol-binding protein II by solid-state NMR, Biochemistry 32, 4560-4563.
83. Bevington, P. R., and Robinson, D. K. (1992) Data Reduction and Error Analysis for the Physical Sciences, McGraw-Hill, Boston.
84. Bak, M., Rasmussen, J. T., and Nielsen, N. C. (2000) SIMPSON: A general simulation program for solid-state NMR spectroscopy, J. Magn. Reson. 147, 296-330.
85. 15N dipole-coupled chemical-shift powder patterns, J. Am. Chem. Soc. 109, 5956-5962.
86. Balbach, J. J., Yang, J., Weliky, D. P., Steinbach, P. J., Tugarinov, V., Anglister, J., and Tycko, R. (2000) Probing hydrogen bonds in the antibody-bound HIV-1 gp120 V3 loop by solid-state NMR REDOR measurements, J. Biomol. NMR 16, 313-327.
87. Derrick, J. P., and Wigley, D. B. (1994) The third IgG-binding domain from streptococcal protein G. An analysis by X-ray crystallography of the structure alone and in a complex with Fab, J. Mol. Biol. 243, 906-918.
88. P. D. Parkanzky and, D. P. Weliky, unpublished experiments.
89. 13C cross polarization magic angle spinning spectroscopic characterization of solid polypeptides, Macromolecules 16, 615-623.
90. 13C NMR, Magn. Reson. Chem. 24, 835-852.
91. Yang, J., Parkanzky, P. D., Khunte, B. A., Canlas, C. G., Yang, R., Gabrys, C. M., and Weliky, D. P. (2001) Solid-state NMR measurements of conformation and conformational distributions in the membrane-bound HIV-1 fusion peptide, J. Mol. Graphics Modell. 19, 129-135.
92. Morcombe, C. R., and Zilm, K. W. (2003) Chemical shift referencing in MAS solid-state NMR, J. Magn. Reson. 162, 479-486.
93. Zhang, H. Y., Neal, S., and Wishart, D. S. (2003) RefDB: A database of uniformly referenced protein chemical shifts, J. Biomol. NMR 25. 173-195.
94. 13C multiple-pulse solid-state NMR, Chem. Phys. Lett. 246, 439-445.
95. Sun, B. Q., Costa, P. R., and Griffin, R. G. (1995) Heteronuclear polarization transfer by radiofrequency-driven dipolar recoupling under magic-angle-spinning, J. Magn. Reson. A 112, 191-198.
96. Mitchell, D. J., and Evans, J. N. S. (1998) Improved heteronuclear decoupling in REDOR with the use of TPPM, Chem. Phys. Lett. 292, 656-660.
97. Mehta, A. K., Hirsh, D. J., Oyler, N., Drobny, G. P., and Schaefer, J. (2000) Carbon-proton dipolar decoupling in REDOR, J. Magn. Reson. 145, 156-158.
98. 15N-labeled peptides, J. Am. Chem. Soc. 123, 3507-3519.
99. 15 with silk I form after removal of the effect of MAS frequency in REDOR experiment, J. Magn. Reson. 160, 91-96.
100. Gullion, T., and Vega, S. (1992) A simple magic angle spinning NMR experiment for the dephasing of rotational echoes of dipolar coupled homonuclear spin pairs, Chem. Phys. Lett. 194, 423-428.
101. Bennett, A. E., Ok, J. H., Griffin, R. G., and Vega, S. (1992) Chemical-shift correlation spectroscopy in rotating solids-radio frequency-driven dipolar recoupling and longitudinal exchange, J. Chem. Phys. 96, 8624-8627.
102. Bennett, A. E., Rienstra, C. M., Griffiths, J. M., Zhen, W. G., Lansbury, P. T., and Griffin, R. G. (1998) Homonuclear radio frequency-driven recoupling in rotating solids, J. Chem. Phys. 108, 9463-9479.
103. Suarez, T., Gomara, M. J., Goni, F. M., Mingarro, I., Muga, A., Perez-Paya, E., and Nieva, J. L. (2003) Calcium-dependent conformational changes of membrane-bound Ebola fusion peptide drive vesicle fusion, FEBS Lett. 535, 23-28.
104. Kim, C. H., Macosko, J. C., Yu, Y. G., and Shin, Y. K. (1996) On the dynamics and confirmation of the HA2 domain of the influenza virus hemagglutinin, Biochemistry 35, 5359-5365.
105. Kim, C. H., Macosko, J. C., and Shin, Y. K. (1998) The mechanism for low-pH-induced clustering of phospholipid vesicles carrying the HA2 ectodomain of influenza hemagglutinin, Biochemistry 37, 137-144.
106. Leikina, E., LeDuc, D. L., Macosko, J. C., Epand, R., Shin, Y. K., and Chemomordik, L. V. (2001) The I-127 HA2 construct of influenza virus hemagglutinin induces cell-cell hemifusion, Biochemistry 40, 8378-8386.
107. Epand, R. F., Yip, C. M., Chernomordik, L. V., LeDuc, D. L., Shin, Y. K., and Epand, R. M. (2001) Self-assembly of influenza hemagglutinin: studies of ectodomain aggregation by in situ atomic force microscopy, Biochim. Biophys. Acta 1513, 167-175.
108. Lansbury, P. T., Jr., Costa, P. R., Griffiths, J. M., Simon, E. J., Auger, M., Halverson, K. J., Kocisko, D. A., Hendsch, Z. S., Ashburn, T. T., Spencer, R. G., Tidor, B., and Griffin, R. G. (1995) Structural model for the β-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide, Nat. Struct. Biol. 2, 990-998.
109. Benzinger, T. L., Gregory, D. M., Burkoth, T. S., Miller-Auer, H., Lynn, D. G., Botto, R. E., and Meredith, S. C. (1998) Propagating structure of Alzheimer's β-amyloid(10-35) is parallel beta-sheet with residues in exact register, Proc. Natl. Acad. Sci. U.S.A. 95, 13407-13412.
110. Antzutkin, O. N., Balbach, J. J., Leapman, R. D., Rizzo, N. W., Reed, J., and Tycko, R. (2000) Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of beta-sheets in Alzheimer's β-amyloid fibrils, Proc. Natl. Acad. Sci. U.S.A. 97, 13045-13050.
111. Saez-Cirion, A., and Nieva, J. L. (2002) Conformational transitions of membrane-bound HIV-1 fusion peptide, Biochim. Biophys. Acta 1564, 57-65.
112. Haque, M. E., and Lentz, B. R. (2002) Influence of gp41 fusion peptide on the kinetics of poly(ethylene glycol)-mediated model membrane fusion, Biochemistry 41, 10866-10876.